Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Phase I/IIa clinical trial for recessive dystrophic epidermolysis bullosa using genetically corrected autologous keratinocytes Siprashvili, Z., Nguyen, N., Gorell, E., Loutit, K., Dutt-Singkh, Y., Nazaroff, J., Khuu, P., Furukawa, L., Lorenz, H., Leung, T., Keene, D., Rieger, K., Khavari, P. A., Lane, A., Tang, J. Y., Marinkovich, M. ELSEVIER SCIENCE INC. 2017: S89
View details for DOI 10.1016/j.jid.2017.02.539
View details for Web of Science ID 000406862400513